BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33059999)

  • 1. Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation.
    Nawas MT; Sheng Y; Huang CY; Andreadis C; Martin TG; Wolf JL; Ai WZ; Kaplan LD; Mannis GN; Logan AC; Damon LE; Olin RL
    J Geriatr Oncol; 2021 May; 12(4):531-539. PubMed ID: 33059999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults.
    Huang LW; Sheng Y; Andreadis C; Logan AC; Mannis GN; Smith CC; Gaensler KML; Martin TG; Damon LE; Huang CY; Olin RL
    Transplant Cell Ther; 2022 Jun; 28(6):309.e1-309.e9. PubMed ID: 35247612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation.
    Nawas MT; Andreadis C; Martin TG; Wolf JL; Ai WZ; Kaplan LD; Mannis GN; Logan AC; Damon LE; Huang CY; Olin RL
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1218-1224. PubMed ID: 30708189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patients.
    Derman BA; Kordas K; Molloy E; Chow S; Dale W; Jakubowiak AJ; Jasielec J; Kline JP; Kosuri S; Lee SM; Liu H; Riedell PA; Smith SM; Bishop MR; Artz AS
    J Geriatr Oncol; 2021 May; 12(4):585-591. PubMed ID: 33162369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geriatric Assessment in Older Adults with Multiple Myeloma.
    Wildes TM; Tuchman SA; Klepin HD; Mikhael J; Trinkaus K; Stockerl-Goldstein K; Vij R; Colditz G
    J Am Geriatr Soc; 2019 May; 67(5):987-991. PubMed ID: 30548581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients.
    Huang LW; Sheng Y; Andreadis C; Logan AC; Mannis GN; Smith CC; Gaensler KML; Martin TG; Damon LE; Steinman MA; Huang CY; Olin RL
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):189-196. PubMed ID: 31493541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes.
    Olin RL; Fretham C; Pasquini MC; Arora M; Bhatt VR; Derman B; Giralt SA; Huang LW; Koll T; Lee SM; Lin RJ; Pang L; Popat UR; Weisdorf DJ; Artz A
    Blood Adv; 2020 Jun; 4(12):2810-2820. PubMed ID: 32574365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care.
    Olin RL
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):63-70. PubMed ID: 31808886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life 5 or more years post-autologous hematopoietic stem cell transplant.
    Byar KL; Eilers JE; Nuss SL
    Cancer Nurs; 2005; 28(2):148-57. PubMed ID: 15815185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma.
    Lemieux C; Ahmad I; Bambace NM; Bernard L; Cohen S; Delisle JS; Fleury I; Kiss T; Mollica L; Roy DC; Sauvageau G; Roy J; Lachance S
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):157-161. PubMed ID: 31521818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care.
    Olin RL
    Blood; 2019 Dec; 134(23):2013-2021. PubMed ID: 31805199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Length of Stay and Health Care Utilization Among Pediatric Autologous Hematopoietic Cell Transplantation Recipients.
    Davis L; Yao Y; Jin Z; Moscoso S; Neunert C; Broglie L; Hall M; Bhatia M; George D; Garvin JH; Satwani P
    Transplant Cell Ther; 2021 Jul; 27(7):613.e1-613.e7. PubMed ID: 33831624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
    El-Jawahri A; LeBlanc T; VanDusen H; Traeger L; Greer JA; Pirl WF; Jackson VA; Telles J; Rhodes A; Spitzer TR; McAfee S; Chen YA; Lee SS; Temel JS
    JAMA; 2016 Nov; 316(20):2094-2103. PubMed ID: 27893130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatment.
    Mian H; Pond GR; Tuchman SA; Fiala MA; Wildes TM
    J Geriatr Oncol; 2020 Nov; 11(8):1279-1284. PubMed ID: 32471776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis.
    Strouse CS; Larson MC; Ehlers SL; Yost KJ; Maurer MJ; Ansell SM; Inwards DJ; Johnston PB; Micallef IN; Link BK; Farooq U; Cerhan JR; Thompson CA
    JCO Oncol Pract; 2022 Jul; 18(7):e1069-e1080. PubMed ID: 35594505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant.
    Rosko AE; Huang Y; Benson DM; Efebera YA; Hofmeister C; Jaglowski S; Devine S; Bhatt G; Wildes TM; Dyko A; Jones D; Naughton MJ; Byrd JC; Burd CE
    J Geriatr Oncol; 2019 May; 10(3):479-485. PubMed ID: 29983352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Patient Reported Outcomes with CAR-T Cell Therapy Versus Autologous and Allogeneic Stem Cell Transplant.
    Sidana S; Dueck AC; Thanarajasingam G; Griffin JM; Thompson C; Durani U; Burtis M; Warsame R; Paludo J; Gertz MA; Dispenzieri A; Ansell SM; Rajkumar SV; Yost K; Bennani N; Lin Y; Kumar S
    Transplant Cell Ther; 2022 Aug; 28(8):473-482. PubMed ID: 35550440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial frailty assessments following allogeneic stem cell transplant in older adults: A pilot study.
    Ombres R; des Bordes JKA; Popat UR; Yennu S; Champlin RE; Mohile SG; Kebriaei P; Holmes HM
    J Geriatr Oncol; 2022 Mar; 13(2):194-199. PubMed ID: 34493481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential Geriatric Assessment in Older Patients with Colorectal Cancer during Chemotherapy: Subgroup Analysis of a Prospective, Multicenter Study EpiReal 75.
    Li M; Schulte N; Elting F; Winkler EC; Hetjens S; Berger AK; Zschäbitz S; Hofmann J; Hofmann J; Hilbertz L; Kuhn M; Khakzar C; Jesenofsky R; Betge J; Zhan T; Belle S; Ebert MP; Härtel N
    Oncol Res Treat; 2022; 45(11):670-680. PubMed ID: 35675788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life following Allogeneic Stem Cell Transplantation for Patients Age >60 Years with Acute Myelogenous Leukemia.
    Wright R; Oremek M; Davies D; Kewley C; Singh A; Taitt N; Kempshall E; Wilson K; Ingram W
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):1527-1533. PubMed ID: 32422252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.